Dark_2020_large.png

Rigorous science done transparently

 

RESEARCH

The science of psychedelic microdosing

microdose

MICRODOSING PSILOCYBIN

Microdosing is more popular than ever, but we still don’t really understand how it works and what it does. There has been a recent groundswell of journalism on the topic, but there is almost no scientific evidence for the effects of this practice. We are preparing a study that will measure the empirical effects of microdosing. Our design will be a double-blind placebo-controlled crossover washout trial. We aim to have 100 participants in our first study.

PUBLICATIONS

We have published some of the first academic research on psychedelic microdosing. Click on the publication link at the top of the page or on the document icon to the left to check them out. You can also scroll down to find media covering our research.

 
 

OUR TEAM

 
RotemHeadshot_03.jpg

ROTEM PETRANKER

Co-Founder and Director

Rotem is a Clinical Psychology PhD student with John Eastwood's lab at York University.  His main research interests are sustained attention, emotional regulation, and creativity, all of which are ostensibly affected by psychedelics. Rotem is passionate about establishing a rigorous framework for the study of psychedelics using the principles of Open Science. His clinical interests include disorders amenable to psychedelic psychotherapy, including mood disorders and OCD.

Thomas Anderson, Co-Founder and Research Director

THOMAS ANDERSON

Co-Founder and Director

Thomas Anderson is a PhD Candidate studying Cognitive Neuroscience at the University of Toronto (Toronto, Canada). Thomas is a strong proponent of open science and publicly communicating scientific findings. He has shared our research findings and presentations on ResearchGate and keeps an active account on Reddit to communicate about this research with the public.

Emily Kulpa, Research Associate

EMILY KULPA

Research Associate

Emily Kulpa, Pharm.D. is a licensed clinical pharmacist with a background in medication therapy management focused on optimizing therapeutic outcomes. She is the Director of Medical Health Screening at Synthesis, a legal, medically supervised, psilocybin retreat centre for professionals to experience personal growth, emotional breakthroughs, and spiritual development.

Joya Square.webp

JOYA HALLS

Digital Content Coordinator

Joya Halls has over two decades of experience working in health care, cannabis and psychedelics. With educational training in health sciences, nursing, pharmacy, and cannabinoid medicine, Joya rounds out her portfolio with extensive experience working in medical cannabis and as a consultant in the psychedelic industry. A particular focus in her career has been working with those with dependency issues, mental health concerns and chronic pain disorders. Joya dedicates her time to helping others as a patient advocate and by volunteering for groups in the cannabis and psychedelics space. 

MEDIA

CONTACT US

Thanks for submitting!

SUBSCRIBE FOR UPDATES